Skip to main content
. 2012 Oct 19;12:482. doi: 10.1186/1471-2407-12-482

Figure 1.

Figure 1

Progression free survival (PFS) according to maintenace Bevacizumb (mBev) combined or not to hormonal therapy (HT) in hormonal receptor positive patients.